29 PROTEOMIC ANALYSIS OF CLONED TERM PLACENTA DERIVED FROM SOMATIC CELL NUCLEAR TRANSFER CATS

2011 ◽  
Vol 23 (1) ◽  
pp. 121
Author(s):  
J. I. Bang ◽  
D. W. Bae ◽  
Y. S. Kwon ◽  
S. J. Cho ◽  
G. K. Deb ◽  
...  

The normal placenta formation and development affect subsequent survival and development of fetus. Somatic cell nuclear transfer (SCNT) is still associated with functional and structural abnormalities of placentation in cloned pregnancy. Moreover, the molecular basis of placenta derived from cloned embryos is poorly understood. To determine the abnormal expression of proteins of cloned term placenta (CTP; n = 3) compared with control placenta (n = 3), a proteomic analysis was performed using 2-DE, MALDI-TOF MS, and MALDI-TOF/TOF MS/MS. The cloned kittens were killed 1 month after Caesarean section. The results showed that 42 proteins were significantly up/down expressed in the CTP (P < 0.05). In CTP, thirty proteins were up-regulated, such as apoptosis-related cathepsin D (CD), annexin A1, and heat shock protein 27, and 12 proteins were down-regulated, such as prohibitin (PHB). Abnormal expression of CD and PHB may be related to induced reactive oxygen species (ROS) resulting in promoted cellular senescence and apoptosis. The expression patterns of CD and PHB were validated by Western blotting and immunofluorescence assay. Additionally, we also confirmed the abnormal expression of SOD (up-regulated) and CAT (down-regulated) enzymes in the CTP. Increased generation of ROS in the CTP was related to decreased mitochondrial membrane potential as detected in placenta tissues by MitoTracker green FM (MTG; 1 μM, Invitrogen, Carlsbad, CA). ROS-induced mitochondrial damage accelerated telomere loss [as detected by IQ-fluorescent in situ hybridization (FISH)] compared with control. ROS is an important modulator of telomere loss and that telomere-driven cellular senescence is primarily a stress responsive. Thus, the data suggest that combined abnormal proteins expression were associated with hindered development of cloned placenta and viability of fetus. Therefore, if we can solve this problem, the efficiency of SCNT and transgenic cat production will be increased, which in turn, may be applied as a potential means of restoration of endangered animals. This work was partly supported by the BK21 program and the KOSEF (10525010001–05N2501–00110).

2007 ◽  
Vol 177 (4S) ◽  
pp. 297-297
Author(s):  
Kristina Schwamborn ◽  
Rene Krieg ◽  
Ruth Knüchel-Clarke ◽  
Joachim Grosse ◽  
Gerhard Jakse

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Effrosyni Fatira ◽  
Miloš Havelka ◽  
Catherine Labbé ◽  
Alexandra Depincé ◽  
Viktoriia Iegorova ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Birbal Singh ◽  
Gorakh Mal ◽  
Vinod Verma ◽  
Ruchi Tiwari ◽  
Muhammad Imran Khan ◽  
...  

Abstract Background The global health emergency of COVID-19 has necessitated the development of multiple therapeutic modalities including vaccinations, antivirals, anti-inflammatory, and cytoimmunotherapies, etc. COVID-19 patients suffer from damage to various organs and vascular structures, so they present multiple health crises. Mesenchymal stem cells (MSCs) are of interest to treat acute respiratory distress syndrome (ARDS) caused by SARS-CoV-2 infection. Main body Stem cell-based therapies have been verified for prospective benefits in copious preclinical and clinical studies. MSCs confer potential benefits to develop various cell types and organoids for studying virus-human interaction, drug testing, regenerative medicine, and immunomodulatory effects in COVID-19 patients. Apart from paving the ways to augment stem cell research and therapies, somatic cell nuclear transfer (SCNT) holds unique ability for a wide range of health applications such as patient-specific or isogenic cells for regenerative medicine and breeding transgenic animals for biomedical applications. Being a potent cell genome-reprogramming tool, the SCNT has increased prominence of recombinant therapeutics and cellular medicine in the current era of COVID-19. As SCNT is used to generate patient-specific stem cells, it avoids dependence on embryos to obtain stem cells. Conclusions The nuclear transfer cloning, being an ideal tool to generate cloned embryos, and the embryonic stem cells will boost drug testing and cellular medicine in COVID-19.


Sign in / Sign up

Export Citation Format

Share Document